Table 2. Correlation of patient survival length with HCFC1 and KHSRP expression.

	HCFC1	HCFC1	KHSRP	KHSRP	KHSRP
	probe 1	probe 2	probe 1	probe 2	probe 3
Total	50.0%	50.0%	50.0%	50.0%	50.0%
(548 patients)
Survival >3 yrs	70.0%*	70.0%*	70.0%*	70.0%*	50.0%
(30 patients)	(p = 0.004)	(p = 0.002)	(p = 0.003)	(p = 0.013)
Survival >5 yrs	91. 7%*	83.3%*	66.7%*	75.0%*	58.3%
(12 patients)	(p = 0.001)	(p = 0.007)	(p = 0.047)	(p = 0.027)

Data are presented as the percentage of patients with expression above median level.